Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
The International Journal of Artificial Organs|September 23, 2020
The impact of arteriovenous fistulas and tunneled cuffed venous catheters on morbidity and mortality in hemodialysis patients: A single center experienceSerhat Celik, Ebru Gok Oguz, Gulay Ulusal Okyay, et al.Clinical Nutrition ESPEN|October 2, 2022
Evaluation of refeeding hypophosphatemia frequency, risk factors, and nutritional status during stem cell transplantation in patients with hematologic malignancySerap Şahin Ergül, Gulsah Gunes Sahin, Nurhayat Tugra Ozer, et al.Medical Oncology (Northwood, London, England)|August 28, 2021
Detection of mutations in CML patients resistant to tyrosine kinase inhibitor: imatinib mesylate therapyNilgun Karasu, Hilal Akalin, Nuriye Gokce, et al.Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|June 27, 2020
Low-dose cyclophosphamide and granulocyte colony-stimulating factor are sufficient for peripheral blood stem cell mobilization in patients with multiple myelomaMuzaffer Keklik, Esen Karakus, Leylagul Kaynar, et al.Annals of Hematology|April 17, 2023
Safety and efficacy of mesenchymal stromal cell therapy for multi-drug-resistant acute and late-acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantationMuzaffer Keklik, Burak Deveci, Serhat Celik, et al.Clinical Lymphoma, Myeloma & Leukemia|October 11, 2021
The Real-World Experience With Single Agent Ibrutinib in Relapsed/Refractory CLLSeval Akpinar, Mehmet Hilmi Dogu, Serhat Celik, et al.BMC Cancer|October 11, 2025
Comprehensive analysis of FLT3-mutated patients with acute myeloid leukemia with updated 2022 European LeukemiaNet recommendations: insights from the Turkish AML registry projectIbrahim Ethem Pinar, Serhat Celik, Merve Gokcen Polat, et al.Journal of Clinical Medicine|October 29, 2025
Clinical Characteristics, Treatment Approaches, and Survival Predictors in Adult Acute Myeloid Leukemia: Interim Results from the Turkish Society of Hematology AML RegistryVolkan Karakus, Ibrahim Ethem Pinar, Utku Iltar, et al.Pageof 1